These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 663394)

  • 1. Inability of accumulated metabolic byproducts of uremia to alter the extent of warfarin binding in charcoal treated plasma.
    Bachmann K; Conway P; Shapiro R
    Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):117-30. PubMed ID: 663394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction of protein binding defect in uremic sera by charcoal treatment.
    Craig WA; Evenson MA; Sarver KP; Wagnild JP
    J Lab Clin Med; 1976 Apr; 87(4):637-47. PubMed ID: 1270877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous accumulation products and serum protein binding in uremia.
    McNamara PJ; Lalka D; Gibaldi M
    J Lab Clin Med; 1981 Nov; 98(5):730-40. PubMed ID: 7299243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced in vitro displacement of valproic acid from protein binding by salicylate in uremic sera compared with normal sera. Role of uremic compounds.
    Dasgupta A; Jacques M
    Am J Clin Pathol; 1994 Mar; 101(3):349-53. PubMed ID: 8135194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the drug-binding defect in plasma from rats with glycerol-induced acute renal failure.
    Bowmer CJ; Lindup WE
    J Pharmacol Exp Ther; 1979 Sep; 210(3):440-5. PubMed ID: 480193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproate plasma protein binding in the uremic condition.
    Brewster D; Muir NC
    Clin Pharmacol Ther; 1980 Jan; 27(1):76-82. PubMed ID: 6985855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of renal dysfunction on warfarin plasma protein binding.
    Bachmann K; Shapiro R; Mackiewicz J
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):468-72. PubMed ID: 977790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Warfarin binding to plasma of workers exposed to toluene diisocyanate.
    Bachmann K; Shapiro R; Forney RB
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):47-50. PubMed ID: 6277811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of carbamylation of plasma proteins and competitive displacers on drug binding in uremia.
    Calvo R; Carlos R; Erill S
    Pharmacology; 1982; 24(4):248-52. PubMed ID: 7089046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of peptides from uremic plasma that inhibit phenytoin binding to normal plasma proteins.
    Kinniburgh DW; Boyd ND
    Clin Pharmacol Ther; 1981 Aug; 30(2):276-80. PubMed ID: 7249510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tienilic acid (Diflurex) on the binding of warfarin 14C to human plasma proteins.
    Prandota J; Albengres E; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1980 Apr; 18(4):158-62. PubMed ID: 7380589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of fasting on the disposition of warfarin in rats.
    Laliberte R; Chakrabarti S; Brodeur J
    J Pharmacol Exp Ther; 1977 Jan; 200(1):44-51. PubMed ID: 833761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of plasma protein binding on the anticoagulant action of warfarin in rats.
    Yacobi A; Levy G
    Res Commun Chem Pathol Pharmacol; 1975 Oct; 12(2):405-8. PubMed ID: 1197921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the oral adsorbent AST-120 on tryptophan metabolism in uremic patients.
    Tsubakihara Y; Takabatake Y; Oka K; Shoji T; Togawa M; Okada N; Takahito I; Imai E
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S38-41. PubMed ID: 12612950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tin-protein binding kinetics in normal and uremic plasma and its effect on dialysis fluxes.
    Maher JF; Montero G; Chieffo S
    Trans Am Soc Artif Intern Organs; 1976; 22():149-54. PubMed ID: 951835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of valproic acid on the serum protein binding of lorazepam and diazepam.
    Calvo R; Carlos R; Erill S
    Int J Clin Pharmacol Res; 1986; 6(3):213-5. PubMed ID: 3091512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of the binding between uric acid and plasma proteins (author's transl)].
    Sforza GR; Marcolongo R; Della Fazia L; Masciangelo F; Morozzi G; Lo Cosmo C
    Quad Sclavo Diagn; 1980 Dec; 15(4):1075-89. PubMed ID: 7454962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of endogenous compounds, isolated from sera of uremic patients, on chloramphenicol binding to proteins.
    Grafnetterová J; Grafnetter D; Schück O; Tomková D; Bláha J
    Biochem Pharmacol; 1979 Oct; 28(19):2923-8. PubMed ID: 518688
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma protein aspartyl damage is increased in hemodialysis patients: studies on causes and consequences.
    Perna AF; Ingrosso D; Satta E; Lombardi C; Galletti P; D'Aniello A; De Santo NG
    J Am Soc Nephrol; 2004 Oct; 15(10):2747-54. PubMed ID: 15466280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum protein binding of diazepam, desmethyldiazepam, furosemide, indomethacin, warfarin, and phenobarbital in human fetus, mother, and newborn infant.
    Nau H; Luck W; Kuhnz W; Wegener S
    Pediatr Pharmacol (New York); 1983; 3(3-4):219-27. PubMed ID: 6429618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.